lunes, 21 de diciembre de 2020

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - The Lancet Rheumatology

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario